Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-76.26	45.91	193.36
Graham Fair Price	-14.26	20.59	24.01
PEG	400.85	-0.76	0.15
Price/Book	-7.76	2.27	2.46
Price/Cash Flow	-44.25	33.11	59.39
Prices/Earnings	31.88	21.80	16.53
Price/Sales	-4.11	16.53	17.24
Price/FCF	-44.25	33.11	59.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.84	0.71	0.76
Operating Margin	64.64	0.24	0.15
ROA	-30.19	0.02	0.03
ROE	0.04	0.03	-30.05
ROIC	0.02	0.02	38.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	-0.08	12.87
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	0.64	12498.46
EPS QOQ	1.09	-0.29	-73.67
FCF QOQ	-0.27	0.71	167.95
Revenue QOQ	< 0.005	< 0.005	-46.78
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	131.46	< 0.005	-100.00
Days Sales Outstanding (DSO)	42.08	41.60	-1.15
Inventory Turnover	0.68	334332000.00	48836524318.13
Debt/Capitalization	< 0.005	< 0.005	-10.04
Quick Ratio	4.26	4.26	0.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26.22	26.88	2.52
Cash	22.77	23.92	5.08
Capex	-0.06	-0.06	1.10
Free Cash Flow	1.09	1.85	69.64
Revenue	3.75	3.70	-1.38
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.50	4.36	-3.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-15.72	-4.93	68.64
Naive Interpretation	Member

06 - Financial Health · Bad

Rating